Hyperglycemia leads to poorer clinical outcomes, with increased morbidity and mortality in both critically ill and non-critically ill people. Improving blood glucose levels reduces length of hospital stay, systemic infections and short- and long-term mortality. Egyptian physicians evaluated the efficacy of insulin degludec compared to insulin glargine and regular insulin in controlling blood glucose levels.
You May Also Like
- Psychooncology
Communication as the key to therapy adherence
- Blastic plasmacytoid dendritic cell neoplasia
Rare malignancy from a dermatological perspective
- From symptom to diagnosis
Lung carcinoma – Pancoast tumor
- Deep vein thrombosis
Outpatient or inpatient treatment?
- From symptom to diagnosis
Abdominal pain – Intraductal papillary mucinous neoplasia
- IBDmatters - Advanced Therapeutic Treatments
Examinations and considerations before therapy
- “Swiss Health Care Atlas”
Supply situation in Switzerland at a glance
- Steatotic liver disease